Fingeraftryk
Dyk ned i forskningsemnerne om 'A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma'. Sammen danner de et unikt fingeraftryk.- Sorter
- Vægt
- Alfabetisk
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma
Teis Esben Søndergaard, PT Pedersen, Thomas Levin Andersen, K Søe, T Lund, B Ostergaard, P Garnero, Jean-Marie Delaissé, T Plesner
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review